Tag: Hair Loss
FDA Warns of Unapproved Hair-Loss Product Linked to Side Effects
Low-Dose Oral Minoxidil Effective for Alopecia in Breast Cancer
All patients receiving surgery/radiotherapy alone or with chemotherapy had improvement or stability of alopecia with LDOM
Consensus Statement Issued for Low-Dose Oral Minoxidil for Hair Loss
Seventy-six items achieved consensus, including indications for LDOM versus topical minoxidil, dosing for adults and teens, contraindications
AAD: Hair Regrowth Continues to Improve at 76 Weeks With Baricitinib for Severe Alopecia
Patients achieving SALT score ≤20 increased from 44.5 to 75.8 percent at week 52 to week 76
Considerable Shortages of Minoxidil Recorded in Greater D.C. Area
Considerable shortages of 2.5, 10 mg minoxidil reported by pharmacies in Washington, D.C., Maryland, and Virginia
JAK Inhibitors May Aid Hair Regrowth in Patients With Alopecia
Study shows safety and tolerability of JAK inhibitors acceptable
FDA Approves Litfulo for Teens, Adults With Alopecia Areata
Approval based on clinical trials, including ALLEGRO Phase 2b/3 trial involving 718 patients with alopecia areata
People With Alopecia Have Higher Risk for Inflammatory Arthritis
Increased risk seen for psoriatic and rheumatoid arthritis, and ankylosing spondylitis
Hair Regrowth Seen in Alopecia With Methotrexate + Prednisone
About 31 percent of patients with recalcitrant alopecia areata totalis or universalis had complete hair regrowth
Burden of Alopecia Areata Significant in the United States
Standardized prevalence highest in those aged 30 to 39, 40 to 49 years; Asians, Blacks, Hispanic/Latinos have increased prevalence ratios
